The multi-crossover model for classifying patients as responders to a given treatment

Scandinavian Journal of Gastroenterology

Volumn 26, Issue 7, 1991, Pages 763-770

  Larsen, S ^a,b,c,d   Farup, P ^a,b,c,d   Flaten, O ^a,b,c,d   Osnes, M ^a,b,c,d  

^a Medstat Centre for Administration Design and Statistical Analysis in Medical Research ^*  (Norway)

^b Dept of Medicine Gjøvik County Hospital ^*  (Norway)

^c Glaxo Wellcome of Norway   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Classification; Cross tabulation model; Multi crossover model; Non ulcer dyspepsia; Placebo; Ranitidine

Indexed keywords

PLACEBO; RANITIDINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE CLASSIFICATION; DYSPEPSIA; FEMALE; HUMAN; MALE; NORWAY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

CLINICAL TRIALS; DOUBLE-BLIND METHOD; DYSPEPSIA; FEMALE; HUMAN; MALE; RANITIDINE; RECURRENCE; RESEARCH DESIGN; STATISTICS;

EID: 0025912238     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529108998597     Document Type: Article

References (16)

1. The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model
2. Single case studies from a statistician's point of view
3. A three years retrospective study of synovectomies in children
4. Cimetidine responders in non-ulcer-dyspepsia
5. Experience with a multi crossover model in dyspepsia
6. Effect of pancreatic enzymes in non-ulcer dyspepsia. A pilot study
7. A double-blind multiple cross-over trial evaluating a transdermal nitroglycerine system versus placebo
8. 2 antagonist response in non-ulcer dyspepsia
9. Carbamazepine therapy in restless legs. Discrimination between responder and non-responder
10. Epidemiology of polyps in the rectum and sigmoid colon. Discriminant analysis for identification of individuals at risk of developing colorectal neoplasia
11. It is possible to characterize recurrent urinary stone formers. Who benefits from thiazide prophylaxis
12. Ranitidine for non-ulcer dyspepsia. The symptomatic effect of ranitidine and classification of responders to treatment
13. Assessing soft data in clinical trials